Physician

Lia E Perez, MD

According to 2025 Medicare claims, Lia Perez, MD (NPI: 1891718607) practices hematopoietic cell transplantation and cellular therapy in the St. Petersburg-Clearwater-Largo, FL market, with the plurality of this provider's patient population coming from Pinellas, FL. This provider's primary affiliated billing organization is H LEE MOFFITT CANCER CTR & RES INST LIFE TIME CANCER SCRN CTR INC (NPI: 1306833595; TIN: 593238640) and primary practice location at 33612-9416.

Perez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 72 traditional Medicare patients, billed 480 HCPCS/CPT codes, and received $33,610 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 518 prescription claims across 73 beneficiaries totaling $2,088,881 in drug costs, led by Jakafi (Ruxolitinib Phosphate). DME data shows 175 claims. Open Payments data shows 13 records totaling $16,984. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $24,110 and ending at $33,610. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $26,055 to $2,088,881. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	79	257	$24,110
2016	82	351	$32,419
2017	80	198	$16,525
2018	95	251	$21,074
2019	104	327	$27,782
2020	107	408	$36,555
2021	80	198	$21,479
2022	63	199	$19,023
2023	63	258	$21,710
2024	72	480	$33,610

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	39	172	$26,055
2016	47	250	$54,168
2017	45	239	$111,257
2018	39	266	$172,410
2019	54	360	$238,177
2020	64	452	$221,965
2021	53	380	$569,677
2022	52	376	$1,316,574
2023	62	407	$1,004,079
2024	73	518	$2,088,881

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	11	$150
2017	N/R	76	$14,242
2018	23	135	$20,306
2019	35	171	$15,087
2020	N/R	73	$5,361
2021	N/R	65	$5,141
2022	N/R	97	$2,473
2023	N/R	129	$4,719
2024	65	175	$3,607

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	44	164	$113
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	21	70	$94
G2212	Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	19	51	$25
G0316	Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th	20	115	$24
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	21	45	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jakafi	Ruxolitinib Phosphate	35	1,350	$1,076,559
Rezurock	Belumosudil Mesylate	32	960	$569,711
Prevymis	Letermovir	20	560	$152,799
Posaconazole	Posaconazole	14	419	$7,716
Sirolimus	Sirolimus	29	1,164	$6,034

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7520	Sirolimus, oral, 1 mg	N	N/R	28	$1,047
J7507	Tacrolimus, immediate release, oral, 1 mg	N	20	56	$913
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	18	51	$903
Q0510	Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant	N	11	11	$392
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	16	29	$351

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$952	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$16,032	Celgene Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Lia E. Perez, MD?

Tedicare shows public-source Medicare data for Lia E. Perez, MD (NPI 1891718607), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Lia E. Perez, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Lia E. Perez, MD?

Lia E. Perez, MD is linked to H LEE MOFFITT CANCER CTR & RES INST LIFE TIME CANCER SCRN CTR INC (billing NPI 1306833595) in the available physician profile data.

Does Lia E. Perez, MD have Open Payments data?

Lia E. Perez, MD has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.